These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Upper gastrointestinal cancer predisposition syndromes. Shah MA; Kurtz RC Hematol Oncol Clin North Am; 2010 Oct; 24(5):815-35. PubMed ID: 20816576 [TBL] [Abstract][Full Text] [Related]
11. Familial and hereditary renal cancer syndromes. Coleman JA Urol Clin North Am; 2008 Nov; 35(4):563-72; v. PubMed ID: 18992610 [TBL] [Abstract][Full Text] [Related]
12. Cutaneous manifestations of internal malignancies: an overview. Pipkin CA; Lio PA Dermatol Clin; 2008 Jan; 26(1):1-15, vii. PubMed ID: 18023767 [TBL] [Abstract][Full Text] [Related]
15. Genetic testing and tumor surveillance for children with cancer predisposition syndromes. Rao A; Rothman J; Nichols KE Curr Opin Pediatr; 2008 Feb; 20(1):1-7. PubMed ID: 18197032 [TBL] [Abstract][Full Text] [Related]
16. Cutaneous markers of internal malignancy. I. Malignant involvement of the skin and the genodermatoses. Poole S; Fenske NA J Am Acad Dermatol; 1993 Jan; 28(1):1-13. PubMed ID: 8425947 [TBL] [Abstract][Full Text] [Related]
19. [Significance of the identification of hereditary cancer for routine oncological diagnosis]. Weissflog G; Wand D; Schwarz R Dtsch Med Wochenschr; 2006 Jan; 131(1-2):26-8. PubMed ID: 16374739 [TBL] [Abstract][Full Text] [Related]